Use of intrauterine devices may decrease risk for ovarian cancer

January 21, 2020
About 14,000 women each year die of ovarian cancer, making it one of the deadliest gynecologic cancers. Moreover, 80% of ovarian cancer diagnoses…

12 important updates for Cervical Cancer Awareness Month

January 14, 2020
Cervical Cancer Awareness Month is observed every January. An estimated 13,800 new cases of invasive cervical cancer will be diagnosed in the United…

FDA News

FDA grants priority review to Lynparza as part of ovarian cancer maintenance regimen

January 13, 2020
The FDA granted priority review to olaparib in combination with bevacizumab as first-line maintenance treatment of women with advanced ovarian…

In the JournalsPerspective

Cancer mortality rate drops 29% between 1991 and 2017

January 8, 2020
Cancer mortality rates dropped by 29% between 1991 and 2017 in the United States, with a 2.2% drop between 2016 and 2017, according to according to…

In the Journals

Proton chemoradiotherapy associated with reduced acute adverse events in locally advanced cancer

January 7, 2020
Proton chemoradiotherapy appeared associated with a substantial reduction in acute adverse events that caused unplanned hospitalizations compared…

In the JournalsPerspective

No significant link found between powder use, ovarian cancer

January 7, 2020
Researchers did not find a significantly higher risk for ovarian cancer in women who used powder in the genital area, according to an analysis of…

In the JournalsPerspective

Infections caused 13% of cancers in 2018

January 6, 2020
In 2018, infections were the cause of 13% of all new cancer diagnoses, totaling 2.2 million new cases worldwide, although these totals do not include…

Meeting News

‘CA-125 is a valuable tool’ for women with ovarian cancer symptoms

December 11, 2019
CA-125 is a “useful test” for ovarian cancer in primary care, especially in symptomatic women aged older than 50 years, according to a…


Take a look back at the top ovarian cancer news from 2019

HemOnc Today, December 10, 2019
In this supplement to HemOnc Today, we have compiled the most-read articles written about ovarian cancer this year.
From risk reducing measures…

Partnership funds research to assess connection between cancer, aging

December 2, 2019
The Partnership for Aging and Cancer Research Program awarded seven grants intended to fund research into the link between aging and cancer. The…

Meeting NewsPerspective

Novel blood tests could improve cancer detection

November 14, 2019
Two novel blood assays demonstrated efficacy in detecting various cancer types at different disease stages, according to results of two studies…

In the JournalsPerspective

Secondary surgery does not prolong survival in recurrent ovarian cancer

November 13, 2019
Secondary surgical cytoreduction followed by chemotherapy did not extend OS compared with chemotherapy alone among women with platinum-sensitive…

Meeting News

Novel bispecific immune cell engager safe, clinically beneficial in HER2-positive tumors

November 10, 2019
NATIONAL HARBOR, Md. — An investigational bispecific T-cell engager appeared safe and demonstrated some clinical activity among patients with…

In the JournalsPerspective

Hyperbaric oxygen therapy safe, effective for treating symptoms of late radiation cystitis

November 7, 2019
Hyperbaric oxygen therapy safely relieved symptoms of late radiation cystitis among patients who received radiotherapy for cancer in the pelvic…

FDA News

FDA restructures, renames office that reviews cancer therapies

November 6, 2019
The FDA office that reviews applications for cancer therapies has been renamed and reorganized. The Center for Drug Evaluation and Research’s…

FDA News

FDA expands Zejula approval for gynecologic cancers

October 23, 2019
The FDA expanded the approval of niraparib for gynecologic cancers. The new indication applies to use of niraparib (Zejula, Tesaro) — a…

Meeting News

Anxiety, depression linked to pain intensity among patients with cancer

October 23, 2019
Higher levels of anxiety and depression among patients with cancer appeared to be associated with more severe disease-related pain, according to…


Deadliest cancers receive less research funding from patient advocacy groups

October 23, 2019
Cancer-related nonprofit organizations play a crucial role in supporting medical research and patient advocacy, generating nearly $6 billion in…


Breast surgery alone may be safer than in combination with plastic, gynecologic surgeries

October 14, 2019
Women who underwent combined breast, plastic reconstructive and gynecologic surgery exhibited higher rates of postoperative complications…

In the Journals

Nivolumab-bevacizumab combination safe, active in relapsed ovarian cancer

October 11, 2019
A combination of nivolumab and bevacizumab appeared safe and induced responses among women with relapsed ovarian cancer, according to results of a…